Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
1.345
-0.165 (-10.93%)
May 14, 2026, 3:32 PM EDT - Market open
Neuronetics Revenue
Neuronetics had revenue of $34.45M in the quarter ending March 31, 2026, with 7.75% growth. This brings the company's revenue in the last twelve months to $151.64M, up 69.52% year-over-year. In the year 2025, Neuronetics had annual revenue of $149.16M with 99.17% growth.
Revenue (ttm)
$151.64M
Revenue Growth
+69.52%
P/S Ratio
0.67
Revenue / Employee
$230,450
Employees
658
Market Cap
93.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 149.16M | 74.27M | 99.17% |
| Dec 31, 2024 | 74.89M | 3.54M | 4.96% |
| Dec 31, 2023 | 71.35M | 6.14M | 9.42% |
| Dec 31, 2022 | 65.21M | 9.89M | 17.89% |
| Dec 31, 2021 | 55.31M | 6.07M | 12.32% |
| Dec 31, 2020 | 49.24M | -13.41M | -21.41% |
| Dec 31, 2019 | 62.66M | 9.88M | 18.72% |
| Dec 31, 2018 | 52.78M | 12.34M | 30.53% |
| Dec 31, 2017 | 40.43M | 6.21M | 18.13% |
| Dec 31, 2016 | 34.23M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 133.93M |
| Outset Medical | 117.59M |
| AVITA Medical | 71.61M |
| LENSAR | 57.70M |
| Rapid Micro Biosystems | 33.59M |
| MaxCyte | 32.29M |
| Spectral AI | 19.65M |
| QT Imaging Holdings | 18.93M |
STIM News
- 7 hours ago - Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - GlobeNewsWire
- 9 days ago - Neuronetics reports Q1 EPS (16c), consensus (17c) - TheFly
- 9 days ago - Neuronetics backs FY26 revenue view $160M-$166M, consensus $162.47M - TheFly
- 9 days ago - Neuronetics Earnings Call Transcript: Q1 2026 - Transcripts
- 9 days ago - Neuronetics Reports First Quarter 2026 Financial and Operating Results - GlobeNewsWire
- 14 days ago - Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call - GlobeNewsWire
- 4 weeks ago - Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners - GlobeNewsWire